Immune cell therapy shows promise for tough skin cancers
Disease control
Recruiting now
This study tests a treatment using a patient's own immune cells (called tumor-infiltrating lymphocytes or TILs) combined with chemotherapy and interleukin-2 for people with advanced cutaneous squamous cell carcinoma or Merkel cell carcinoma who have already tried immunotherapy. T…
Phase: PHASE2 • Sponsor: Karam Khaddour, MD, MS • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC